Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Rosseti Lenenergo approved dividends for 2023

6/19/24 LSNG

Severstal updated the development strategy of Olenegorsk Mining and Processing Division

6/19/24 CHMF

Vysokoye mine produced its first gold

6/19/24 UGLD

Astra will engage in import substitution in the authorities of Khanty-Mansi Autonomous Okrug

6/19/24 ASTR

Element will start producing components for base stations in 2025

6/19/24 ELMT

Etalon Group commissioned a new phase of iLona Residential Complex

6/19/24 ETLN

EuroTrans opened the second exchange offer window

6/19/24 EUTR

Moscow Exchange added 11 OTC shares

6/19/24 MOEX

Startup Freedom.bi has closed the round

6/18/24 OTCI

Shareholders of Levenhuk approved dividends

6/18/24 LVHK